JIM HILEPO: Open Payments
NPI 1679671317 · LAKE SUCCESS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$863 in 41 payments from 22 companies in 2025. Trend: 2023 $1,016 · 2024 $1,102 · 2025 $863
Food & beverage: $863
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $121 |
| Lilly USA, LLC | 4 | $76 |
| Novartis Pharmaceuticals Corporation | 4 | $73 |
| Abbott Laboratories | 3 | $72 |
| OPKO Pharmaceuticals, LLC | 4 | $65 |
| Mallinckrodt Hospital Products Inc. | 2 | $49 |
| Amgen Inc. | 2 | $40 |
| Alexion Pharmaceuticals, Inc. | 2 | $39 |
| Novo Nordisk Inc | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $32 |
Products named: JYNARQUE, LEQVIO, RAYALDEE, MOUNJARO, JARDIANCE, FREESTYLE LIBRE 3, Wegovy, ACTHAR.
Industry payments across NY — which companies pay providers there.
